All posts by
Researchers at the 3rd International Symposium on Lung-Sparing Therapies for Mesothelioma Present Promising Treatments for Extending Survival and Improving Quality of Life for Victims
By Patricia Kirk
An international roster of distinguished Mesothelioma (MPM) experts came together on Saturday, May 18, in Santa Monica, Calif., to discuss their latest research on lung-sparing therapies for MPM, a rare form of cancer that usually results from exposure to asbestos and commonly affects the pleura, or outer lining of the lungs, and chest wall.
Hosted by the Pacific Heart, Lung and Blood Institute and UCLA, the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma focused on research aimed at preserving vital lung function in mesothelioma patients. Presentations included the latest surgical techniques for removal of cancerous tumors and adjunct techniques and therapies to kill residual cancer cells following surgery and stop tumor growth.